Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study

Alberto Zanchetti1, Cesare Cuspidi, Lisa Comarella

  • 1Centro di Fisiologia Clinica, University of Milan, Ospedale Maggiore Milan, Italy. alberto.zanchetti@unimi.it

Journal of Hypertension
|September 22, 2007
PubMed

Insights

Diastolic dysfunction is common in elderly hypertensive patients without chronic heart failure (CHF). This study found that 25.8% of patients met primary criteria for diastolic dysfunction, highlighting its prevalence in this demographic.

Area of Science:

  • Cardiology
  • Geriatrics
  • Hypertension Research

Background:

  • Chronic heart failure (CHF) often involves diastolic dysfunction, particularly in the elderly and hypertensive individuals.
  • The prevalence of diastolic dysfunction in elderly hypertensive patients without CHF has not been systematically studied.

Purpose of the Study:

  • To determine the prevalence of echocardiographic signs of diastolic dysfunction in elderly hypertensive patients without CHF.
  • To identify demographic and clinical factors associated with diastolic dysfunction in this population.

Main Methods:

  • A cross-sectional observational study (APROS-diadys) involving elderly (>/= 65 years) hypertensive patients without systolic dysfunction (LVEF >/= 45%).
  • Echocardiographic Doppler examination was used to assess diastolic dysfunction based on primary (E/A ratio < 0.7 or > 1.5) and secondary criteria.
  • Data from 2545 patients across 107 clinics in Italy were analyzed.

Main Results:

  • Diastolic dysfunction was identified in 25.8% of patients based on primary criteria.
  • Age, gender, left ventricular mass, systolic and pulse pressures, and midwall shortening fraction were significant covariates.
  • Using secondary criteria, the prevalence increased to 45.6%.

Conclusions:

  • Diastolic dysfunction is highly prevalent in elderly hypertensive patients attending hospital clinics.
  • These findings underscore the importance of screening for diastolic dysfunction in this at-risk group.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...